Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Tumour Amphiregulin, Epiregulin and Epidermal Growth Factor Receptor (EGFR) Expression and Response to Anti-EGFR Agents in Colorectal Cancer

NCT03986541 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT03986541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03986541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Tumour Amphiregulin, Epiregulin and Epidermal Growth Factor Receptor (EGFR) Expression and Response to Anti-EGFR Agents in Colorectal Cancer
Lead sponsor
University of Leeds
Phase
Observational
Overall status
Completed
Start date
September 23, 2019
Completion date
July 22, 2022
Enrollment
541 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer stage iv